Unacceptable principal diagnosis codes

Unacceptable principal diagnosis codes. — See additional coding rules

T37.95XD Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
T37.95XS Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
T37.96XA Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter
T37.96XD Underdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter
T37.96XS Underdosing of unspecified systemic anti-infectives and antiparasitics, sequela
T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
T38.0X5S Adverse effect of glucocorticoids and synthetic analogues, sequela
T38.0X6A Underdosing of glucocorticoids and synthetic analogues, initial encounter
T38.0X6D Underdosing of glucocorticoids and synthetic analogues, subsequent encounter
T38.0X6S Underdosing of glucocorticoids and synthetic analogues, sequela
T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
T38.1X5D Adverse effect of thyroid hormones and substitutes, subsequent encounter
T38.1X5S Adverse effect of thyroid hormones and substitutes, sequela
T38.1X6A Underdosing of thyroid hormones and substitutes, initial encounter
T38.1X6D Underdosing of thyroid hormones and substitutes, subsequent encounter
T38.1X6S Underdosing of thyroid hormones and substitutes, sequela
T38.2X5A Adverse effect of antithyroid drugs, initial encounter
T38.2X5D Adverse effect of antithyroid drugs, subsequent encounter
T38.2X5S Adverse effect of antithyroid drugs, sequela
T38.2X6A Underdosing of antithyroid drugs, initial encounter
T38.2X6D Underdosing of antithyroid drugs, subsequent encounter
T38.2X6S Underdosing of antithyroid drugs, sequela
T38.3X5A Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
T38.3X5D Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
T38.3X5S Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
T38.3X6A Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
T38.3X6D Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
T38.3X6S Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
T38.4X5A Adverse effect of oral contraceptives, initial encounter
T38.4X5D Adverse effect of oral contraceptives, subsequent encounter
T38.4X5S Adverse effect of oral contraceptives, sequela
T38.4X6A Underdosing of oral contraceptives, initial encounter
T38.4X6D Underdosing of oral contraceptives, subsequent encounter
T38.4X6S Underdosing of oral contraceptives, sequela
T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
T38.5X5D Adverse effect of other estrogens and progestogens, subsequent encounter
T38.5X5S Adverse effect of other estrogens and progestogens, sequela
T38.5X6A Underdosing of other estrogens and progestogens, initial encounter
T38.5X6D Underdosing of other estrogens and progestogens, subsequent encounter
T38.5X6S Underdosing of other estrogens and progestogens, sequela
T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.6X5D Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T38.6X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T38.6X6A Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.6X6D Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T38.6X6S Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
T38.7X5D Adverse effect of androgens and anabolic congeners, subsequent encounter
T38.7X5S Adverse effect of androgens and anabolic congeners, sequela
T38.7X6A Underdosing of androgens and anabolic congeners, initial encounter
T38.7X6D Underdosing of androgens and anabolic congeners, subsequent encounter
T38.7X6S Underdosing of androgens and anabolic congeners, sequela
T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
T38.805D Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
T38.805S Adverse effect of unspecified hormones and synthetic substitutes, sequela
T38.806A Underdosing of unspecified hormones and synthetic substitutes, initial encounter
T38.806D Underdosing of unspecified hormones and synthetic substitutes, subsequent encounter
T38.806S Underdosing of unspecified hormones and synthetic substitutes, sequela
T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.815D Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T38.815S Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
T38.816A Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.816D Underdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T38.816S Underdosing of anterior pituitary [adenohypophyseal] hormones, sequela
T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
T38.895D Adverse effect of other hormones and synthetic substitutes, subsequent encounter
T38.895S Adverse effect of other hormones and synthetic substitutes, sequela
T38.896A Underdosing of other hormones and synthetic substitutes, initial encounter
T38.896D Underdosing of other hormones and synthetic substitutes, subsequent encounter
T38.896S Underdosing of other hormones and synthetic substitutes, sequela
T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
T38.905D Adverse effect of unspecified hormone antagonists, subsequent encounter
T38.905S Adverse effect of unspecified hormone antagonists, sequela
T38.906A Underdosing of unspecified hormone antagonists, initial encounter
T38.906D Underdosing of unspecified hormone antagonists, subsequent encounter
T38.906S Underdosing of unspecified hormone antagonists, sequela
T38.995A Adverse effect of other hormone antagonists, initial encounter
T38.995D Adverse effect of other hormone antagonists, subsequent encounter
T38.995S Adverse effect of other hormone antagonists, sequela
T38.996A Underdosing of other hormone antagonists, initial encounter
T38.996D Underdosing of other hormone antagonists, subsequent encounter
T38.996S Underdosing of other hormone antagonists, sequela
T39.015A Adverse effect of aspirin, initial encounter
T39.015D Adverse effect of aspirin, subsequent encounter
T39.015S Adverse effect of aspirin, sequela
T39.016A Underdosing of aspirin, initial encounter
T39.016D Underdosing of aspirin, subsequent encounter
T39.016S Underdosing of aspirin, sequela
T39.095A Adverse effect of salicylates, initial encounter
T39.095D Adverse effect of salicylates, subsequent encounter
T39.095S Adverse effect of salicylates, sequela
T39.096A Underdosing of salicylates, initial encounter
T39.096D Underdosing of salicylates, subsequent encounter
T39.096S Underdosing of salicylates, sequela
T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter
T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela
T39.1X6A Underdosing of 4-Aminophenol derivatives, initial encounter
T39.1X6D Underdosing of 4-Aminophenol derivatives, subsequent encounter